HEARTSCIENCES INC
HSCSNASDAQTrading Snapshot
- Day Range
- $4.01 β $4.11
- 52-Week Range
- $1.63 β $5.25
- Volume
- $4.16B
- Avg Volume
- $4.04B
- Shares Outstanding
- 2.2M
- Next Earnings
- Nov 8, 2026
Fundamentals Snapshot
- Annual Revenue
- $4,319
- Last Q Revenue
- $2,100
- P/E Ratio
- -1.3
- P/S Ratio
- 1961.7x
- EPS (TTM)
- $-2.80
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +186.2%
Why Investors Own HSCS
- βHigh-growth profile β revenue up +44.0% YoY with expanding US Equity exposure.
- βHealthy economics β 74% gross margin and 16% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HEARTSCIENCES INC
HSCS
StockOtter Β· stockotter.spaceAbout HEARTSCIENCES INC
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. (βFortitudeβ or the βCompanyβ), a vertically-integrated digital asset mining platform anchored in Zcash, today announced the appointment of Kimberly Pittma
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates
HeartSciences Inc. (HSCS) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $1.58 per share a year ago.
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Fortitude purchased approximately $1,000,000 of HeartSciences' shares of common stock at $2.43 per share, a 22% premium to the closing price on the purchase date The exchange ratio under the merger agreement with Fortitu
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
Fortitude Mining Holdings, Inc. ("Fortitude" or the Γ’ΒΒCompanyΓ’ΒΒ), a vertically-integrated digital asset mining platform anchored in Zcash today announced it h
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company's shareholders Fiscal 2026 saw the full commercial launch of the MyoVista Insig